160 results
Page 4 of 8
8-K
EX-99.1
pv187ruys8krm8atio
30 Mar 22
Replimune Provides New Clinical Data, Broad Program Update and Future Development Strategy for its Tumor-Directed Oncolytic Immunotherapies
7:28am
8-K
EX-99.1
2avqa i3rc
3 Feb 22
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
8:16am
8-K
EX-99.1
lk605f
31 Jan 22
Replimune Announces the Departure of Dr. Otello Stampacchia from its Board of Directors
4:15pm
8-K
EX-99.1
kmpocyue
10 Jan 22
Replimune Provides 2021 Year End Review and Overview of Expected 2022 Milestones
8:29am
8-K
EX-99.1
y4w9l
4 Nov 21
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
8:13am
8-K
EX-99.1
m6kg16
6 Aug 21
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.1
sqtdofkclc44nzc6bx
3 Jun 21
Other Events
8:03am
8-K
EX-99.1
6z47e8fuse4c kj0
20 May 21
Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
3o8l4
5 May 21
Other Events
8:33am